Matthew D Hall

Citée par

	Toutes	Depuis 2020
Citations	18569	11058
indice h	66	53
indice i10	157	140

2500

1250

625

1875

20052006200720082009201020112012201320142015201620172018201920202021202220232024202555 77 128 147 215 296 451 474 583 614 677 744 826 894 1172 1724 2459 2362 2016 2015 449

Accès public

Tout afficher

153 articles

2 articles*

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Anton SimeonovNational Institutes of HealthAdresse e-mail validée de mail.nih.gov
Kyle R BrimacombeAdresse e-mail validée de mail.nih.gov
Ajit JadhavPfizerAdresse e-mail validée de pfizer.com
Jacob S. RothMD-PhD candidate, Albert Einstein College of MedicineAdresse e-mail validée de einsteinmed.edu
Dorian CheffNational Center for Advancing Translational Science ETB, Karolinska Institutet MBBAdresse e-mail validée de nih.gov
Richard T EastmanNovartis Institutes for BioMedical Research- Global HealthAdresse e-mail validée de novartis.com
Pavitra KannanKarolinska InstitutetAdresse e-mail validée de ki.se
Catherine Z ChenNational Center for Advancing Translational SciencesAdresse e-mail validée de mail.nih.gov
Mark HendersonNational Center for Advancing Translational SciencesAdresse e-mail validée de mail.nih.gov
Stephen C KalesNational Center for Advancing Translational SciencesAdresse e-mail validée de mail.nih.gov
Richard CallaghanUniversity of LeedsAdresse e-mail validée de leeds.ac.uk
Suresh V. AmbudkarDeputy Chief, LCB, CCR, National Cancer Institute, NIHAdresse e-mail validée de mail.nih.gov
Victor W PikeChief of PET Radiopharmaceutical SciencesAdresse e-mail validée de mail.nih.gov
Wei ZhengNational Center for Advancing Translational Sciences, National Institutes of HealthAdresse e-mail validée de mail.nih.gov
James MadiganStaff Scientist, National Cancer InstituteAdresse e-mail validée de nih.gov
Alexey ZakharovNational Institutes of HealthAdresse e-mail validée de nih.gov
gergely szakacsInstitute of EnzymologyAdresse e-mail validée de biomembrane.hu
Kaitlyn SadtlerNational Institutes of HealthAdresse e-mail validée de nih.gov
Matthew DrewFrederick National Laboratory for Cancer ResearchAdresse e-mail validée de nih.gov
Adam YasgarNational Institutes of Health (NIH); National Center for Advancing Translational Sciences (NCATS)Adresse e-mail validée de mail.nih.gov

Suivre

Matthew D Hall

National Center for Advancing Translational Sciences (NCATS)

Adresse e-mail validée de mail.nih.gov - Page d'accueil

rare diseases experimental therapeutics cisplatin assay development antivirals


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Revisiting the role of ABC transporters in multidrug-resistant cancer RW Robey, KM Pluchino, MD Hall, AT Fojo, SE Bates, MM Gottesman Nature Reviews Cancer 18 (7), 452-464, 2018	1618	2018
Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes DW Shen, LM Pouliot, MD Hall, MM Gottesman Pharmacological reviews 64 (3), 706-721, 2012	1082	2012
Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19 RT Eastman, JS Roth, KR Brimacombe, A Simeonov, M Shen, S Patnaik, ... ACS central Science 6 (5), 672-683, 2020	1022	2020
The discovery and development of cisplatin RA Alderden, MD Hall, TW Hambley Journal of chemical education 83 (5), 728, 2006	774	2006
Platinum (IV) antitumour compounds: their bioinorganic chemistry MD Hall, TW Hambley Coordination Chemistry Reviews 232 (1-2), 49-67, 2002	754	2002
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy MD Hall, M Okabe, DW Shen, XJ Liang, MM Gottesman Annu. Rev. Pharmacol. Toxicol. 48 (1), 495-535, 2008	620	2008
Basis for design and development of platinum (IV) anticancer complexes MD Hall, HR Mellor, R Callaghan, TW Hambley Journal of medicinal chemistry 50 (15), 3403-3411, 2007	529	2007
Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes MD Hall, KA Telma, KE Chang, TD Lee, JP Madigan, JR Lloyd, ... Cancer research 74 (14), 3913-3922, 2014	384	2014
Cisplatin is retained in the cochlea indefinitely following chemotherapy AM Breglio, AE Rusheen, ED Shide, KA Fernandez, KK Spielbauer, ... Nature communications 8 (1), 1654, 2017	368	2017
Collateral sensitivity as a strategy against cancer multidrug resistance KM Pluchino, MD Hall, AS Goldsborough, R Callaghan, MM Gottesman Drug Resistance Updates 15 (1-2), 98-105, 2012	361	2012
Toward a Better Understanding of the Complexity of Cancer Drug Resistance MM Gottesman, O Lavi, MD Hall, JP Gillet Pharmacology and Toxicology 56, 2016, 2015	352	2015
Is resistance useless? Multidrug resistance and collateral sensitivity MD Hall, MD Handley, MM Gottesman Trends in pharmacological sciences 30 (10), 546-556, 2009	317	2009
Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells H Sarin, AS Kanevsky, H Wu, KR Brimacombe, SH Fung, AA Sousa, ... Journal of translational medicine 6, 1-15, 2008	314	2008
Fluorescence polarization assays in high-throughput screening and drug discovery: a review MD Hall, A Yasgar, T Peryea, JC Braisted, A Jadhav, A Simeonov, ... Methods and Applications in Fluorescence 4 (2), 022001, 2016	250	2016
Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications P Kannan, C John, SS Zoghbi, C Halldin, MM Gottesman, RB Innis, ... Clinical Pharmacology & Therapeutics 86 (4), 368-377, 2009	226	2009
Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance G Szakács, MD Hall, MM Gottesman, A Boumendjel, R Kachadourian, ... Chemical reviews 114 (11), 5753-5774, 2014	225	2014
Synthesis, activity, and pharmacophore development for isatin-β-thiosemicarbazones with selective activity toward multidrug-resistant cells MD Hall, NK Salam, JL Hellawell, HM Fales, CB Kensler, JA Ludwig, ... Journal of medicinal chemistry 52 (10), 3191-3204, 2009	216	2009
Manganese Transport and Trafficking: Lessons Learned from Saccharomyces cerevisiae VC Culotta, M Yang, MD Hall Eukaryotic cell 4 (7), 1159-1165, 2005	214	2005
The “specific” P-glycoprotein inhibitor tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2) P Kannan, S Telu, S Shukla, SV Ambudkar, VW Pike, C Halldin, ... ACS chemical neuroscience 2 (2), 82-89, 2011	203	2011
The cellular distribution and oxidation state of platinum (II) and platinum (IV) antitumour complexes in cancer cells MD Hall, CT Dillon, M Zhang, P Beale, Z Cai, B Lai, APJ Stampfl, ... JBIC Journal of Biological Inorganic Chemistry 8, 726-732, 2003	198	2003

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs